Not Medicare Enrolled

Dr. Deborah Friedman, M.D.

Neuro-ophthalmology Physician · Dallas, TX
12740 HILLCREST RD STE 269, Dallas, TX 75230
9727739003
Registered in NPPES since 2006
NPI: 1023036340 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Friedman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friedman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Friedman

Dr. Deborah Friedman is a neuro-ophthalmology physician in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Friedman received a total of $378,658 from 30 pharmaceutical and/or device companies across 502 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Friedman is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $378,658 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$378,658
Total received (2018-2024)
Avg $54,094/year across 7 years
Top 14% in TX for neuro-ophthalmology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
502
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$66,948
2023
$75,532
2022
$34,715
2021
$21,196
2020
$15,855
2019
$37,348
2018
$127,063

Payments by company (2024)

ABBVIE INC.
$15,807
Axsome Therapeutics, Inc.
$14,066
PFIZER INC.
$11,513
PFIZER CHILE S.A.
$8,740
PFIZER S.A.
$7,240
SCILEX PHARMACEUTICALS INC.
$5,451
Amneal Pharmaceuticals LLC
$2,854
Tonix Medicines, Inc.
$500
Lundbeck LLC
$376
Teva Pharmaceuticals USA, Inc.
$240
PFIZER INTERNATIONAL LLC
$76
Eli Lilly and Company
$51
Lilly USA, LLC
$34
Top 3 companies account for 61.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$62,802
Teva Pharmaceuticals USA, Inc.
$51,773
ABBVIE INC.
$45,263
Lilly USA, LLC
$37,065
PFIZER INC.
$27,048
Supernus Pharmaceuticals, Inc.
$25,706
Eli Lilly and Company
$23,127
Allergan Inc.
$14,967
Axsome Therapeutics, Inc.
$14,066
PFIZER INTERNATIONAL LLC
$13,245
Lundbeck LLC
$12,951
BioDelivery Sciences International, Inc.
$8,957
PFIZER CHILE S.A.
$8,740
IMPEL PHARMACEUTICALS INC.
$8,025
PFIZER S.A.
$7,240
SCILEX PHARMACEUTICALS INC.
$5,451
AbbVie Inc.
$4,117
Amneal Pharmaceuticals LLC
$2,854
Novartis Pharmaceuticals Corporation
$2,610
Promius Pharma LLC
$1,307
Tonix Medicines, Inc.
$500
Siemens Medical Solutions USA, Inc.
$331
Stryker Corporation
$123
Allergan, Inc.
$94
Avanir Pharmaceuticals, Inc.
$91
Biohaven Pharmaceutical Holding Company Ltd.
$88
UPSHER-SMITH LABORATORIES LLC
$57
SK Life Science, Inc.
$21
Upsher-Smith Laboratories LLC
$21
Pernix Therapeutics Holdings, Inc.
$19
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ARTIS icono biplane · Aimovig · Artis Q · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · COPAXONE · ELYXYB - CELECOXIB · EMGALITY · NSE - NASOPORE OTOPORE · NURTEC ODT · ONZETRA Xsail · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · TREXIMET · TROKENDI XR · Trudhesa · UBRELVY · VYEPTI · ZAVZPRET · ZEMBRACE SYMTOUCH · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neuro-ophthalmology physician in Dallas?
Compare neuro-ophthalmology physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse neuro-ophthalmology physicians nearby

Geographic Context

Neuro-ophthalmology physicians in nearby ZIP areas
3
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Friedman is a neuro-ophthalmology physician, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Friedman receive payments from pharmaceutical companies?
Yes. Dr. Friedman received a total of $378,658 from 30 companies across 502 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Friedman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Neuro-Ophthalmology Physicians in Dallas
Browse neuro-ophthalmology physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Neuro-Ophthalmology Physicians in TX
Neuro-ophthalmology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neuro-Ophthalmology Physicians in TX
Which TX neuro-ophthalmology physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →